These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3092893

  • 21. The effect of estramustine phosphate on prostatic cancer estimated by transrectal ultrasonotomography.
    Watanabe H, Ohe H, Ando K, Sawamura Y, Niijima T, Nakamura S, Orikasa S, Tanahashi Y, Imamura K, Yoshida H.
    Prostate; 1981; 2(2):155-61. PubMed ID: 7301654
    [Abstract] [Full Text] [Related]

  • 22. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC.
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract] [Full Text] [Related]

  • 23. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis.
    Daehlin L, Södergård R, Damber JE.
    Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367
    [Abstract] [Full Text] [Related]

  • 24. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A, Zattoni F, Frustaci S, Galligioni E, Tirelli U, Trovó G, Tumolo S, Merlo A, Artuso G, Cosciani-Cunico S, Grigoletto E.
    Prostate; 1982 Apr; 3(2):159-64. PubMed ID: 7088731
    [Abstract] [Full Text] [Related]

  • 25. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H, Shida K.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M.
    Actas Urol Esp; 1984 Mar; 8(5):399-402. PubMed ID: 6524487
    [No Abstract] [Full Text] [Related]

  • 27. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977 Mar; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 28. Effect of estramustine phosphate on free androgens. A comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer.
    Van Poppel H, Werbrouck PW, Baert L.
    Acta Urol Belg; 1990 Mar; 58(4):89-95. PubMed ID: 2093302
    [Abstract] [Full Text] [Related]

  • 29. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [Abstract] [Full Text] [Related]

  • 30. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ, Andersson SB, Björk P, Gunnarsson PO, Fritjofsson A.
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [Abstract] [Full Text] [Related]

  • 31. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N, Kirdani RY, Murphy GP, Sandberg AA.
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [Abstract] [Full Text] [Related]

  • 32. Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer.
    Boccardo F, Decensi A, Guarneri D, Martorana G, Giberti C, Giuliani L.
    Cancer Chemother Pharmacol; 1988 Feb; 22(2):172-4. PubMed ID: 3409448
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC, Fosså SD, Kaalhus O.
    Tidsskr Nor Laegeforen; 1984 Oct 10; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract] [Full Text] [Related]

  • 34. Rectal palpation and transrectal fine needle aspiration of the prostate in the monitoring of prostate cancer: a study of 59 patients during treatment with estramustine phosphate or estrogens.
    Hedlund PO, Das D, Löwhagen T, Esposti P.
    Prostate; 1989 Oct 10; 15(4):327-33. PubMed ID: 2594583
    [Abstract] [Full Text] [Related]

  • 35. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R, Kaufman J, Mittelman A, Murphy GP.
    J Urol; 1977 Mar 10; 117(3):332-5. PubMed ID: 839597
    [Abstract] [Full Text] [Related]

  • 36. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T, Mitsuya H, Honda N, Fukatu H, Aota Y, Shinoda M, Yoshida K, Sobajima T, Ohishi M, Tsumura Y.
    Hinyokika Kiyo; 1989 Jan 10; 35(1):179-85. PubMed ID: 2729015
    [Abstract] [Full Text] [Related]

  • 37. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP, Slack NH, Mittelman A.
    Semin Oncol; 1983 Sep 10; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract] [Full Text] [Related]

  • 38. Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of prostate.
    Kjaer TB, Nilsson T, Madsen PO.
    Urology; 1975 Jun 10; 5(6):802-4. PubMed ID: 1136096
    [Abstract] [Full Text] [Related]

  • 39. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F, Esposti PL, Andersson L.
    Scand J Urol Nephrol Suppl; 1980 Jun 10; 55():139-42. PubMed ID: 6938017
    [Abstract] [Full Text] [Related]

  • 40. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C, Vekemans M.
    Acta Endocrinol (Copenh); 1976 Sep 10; 83(1):9-14. PubMed ID: 989226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.